Full Name
Derek John Hausenloy
Variants
Derek J. Hausenloy
 
Main Affiliation
 
 
Email
gmsdjh@nus.edu.sg
 

Publications

Results 21-40 of 77 (Search time: 0.021 seconds).

Issue DateTitleAuthor(s)
212013Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent mannerHausenloy D.J. ; Whittington H.J.; Wynne A.M.; Begum S.S.; Theodorou L.; Riksen N.; Mocanu M.M.; Yellon D.M.
222014DJ-1 protects against cell death following acute cardiac ischemiareperfusion injuryDongworth, R.K; Mukherjee, U.A; Hall, A.R; Astin, R; Ong, S.-B ; Yao, Z; Dyson, A; Szabadkai, G; Davidson, S.M; Yellon, D.M; Hausenloy, D.J 
232020Editorial: New Advances in RNA TargetingIlinskaya, O.; Hausenloy, D.J. ; Cabrera-Fuentes, H.A.; Zenkova, M.
242019Effect of ischemic preconditioning and postconditioning on exosome-rich fraction microrna levels, in relation with electrophysiological parameters and ventricular arrhythmia in experimental closed-chest reperfused myocardial infarctionSpannbauer, A.; Traxler, D.; Lukovic, D.; Zlabinger, K.; Winkler, J.; Gugerell, A.; Ferdinandy, P.; Hausenloy, D.J. ; Pavo, N.; Emmert, M.Y.; Hoerstrup, S.P.; Jakab, A.; Gyöngyösi, M.; Riesenhuber, M.
252016Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study - A Single-Center, Blinded, Randomized Controlled TrialChung, R; Maulik, A; Hamarneh, A; Hochhauser, D; Hausenloy, D.J ; Walker, J.M; Yellon, D.M
2614-Oct-2021Effect of remote ischaemic conditioning on infarct size and remodelling in ST-segment elevation myocardial infarction patients: the CONDI-2/ERIC-PPCI CMR substudyFrancis, Rohin; Chong, Jun ; Ramlall, Manish; Bucciarelli-Ducci, Chiara; Clayton, Tim; Dodd, Matthew; Engstrøm, T.; Evans, Richard; Ferreira, Vanessa M.; Fontana, Marianna; Greenwood, John P.; Kharbanda, Rajesh K.; Kim, Won Yong; Kotecha, Tushar; Lønborg, J.T.; Mathur, Anthony; Møller, U.K.; Moon, James; Perkins, Alexander; Rakhit, Roby D.; Yellon, Derek M.; Bøtker, H.E.; Bulluck, Heerajnarain; Hausenloy, Derek J. 
271-Aug-2018First Medical Contact-to-Device Time and Heart Failure Outcomes Among Patients Undergoing Primary Percutaneous Coronary InterventionLoh, Joshua P ; Tan, Li-Ling ; Zheng, Huili ; Lau, Yee-How; Chan, Siew-Pang ; Tan, Kelvin-Bryan; Chua, Terrance ; Tan, Huay-Cheem ; Foo, David ; Lee, Chee-Wan ; Tong, Khim-Leng ; Foo, Ling-Li; Hausenloy, Derek ; Sahlen, Anders ; Yeo, Khung-Keong ; Fox, Keith AA; Wang, Tracy Y; Richards, A Mark ; Chan, Mark Y 
282017Full left ventricular coverage is essential for the accurate quantification of the area-at-risk by T1 and T2 mappingBulluck, H; Bryant, J.A; Lim, M.X ; Tan, X.W; Ramlall, M; Francis, R; Kotecha, T; Cabrera-Fuentes, H.A ; Knight, D.S; Fontana, M; Moon, J.C; Hausenloy, D.J 
29Mar-2019FURIN Inhibition Reduces Vascular Remodeling and Atherosclerotic Lesion Progression in MiceYakala, Gopala K; Cabrera-Fuentes, Hector A ; Crespo-Avilan, Gustavo E ; Rattanasopa, Chutima; Burlacu, Alexandrina; George, Benjamin L ; Anand, Kaviya; Mayan, David Castano ; Corliano, Maria; Hernandez-Resendiz, Sauri ; Wu, Zihao ; Schwerk, Anne MK; Tan, Amberlyn LJ; Trigueros-Motos, Laia; Chevre, Raphael; Chua, Tricia; Kleemann, Robert; Liehn, Elisa A; Hausenloy, Derek J ; Ghosh, Sujoy ; Singaraja, Roshni R 
302016Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarctionHall, A.R; Burke, N; Dongworth, R.K; Kalkhoran, S.B; Dyson, A; Vicencio, J.M; Dorn, G.W; Yellon, D.M; Hausenloy, D.J 
312014HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition poreOng, S.-G; Lee, W.H; Theodorou, L; Kodo, K; Lim, S.Y; Shukla, D.H; Briston, T; Kiriakidis, S; Ashcroft, M; Davidson, S.M; Maxwell, P.H; Yellon, D.M; Hausenloy, D.J 
322016Impact of microvascular obstruction on semiautomated techniques for quantifying acute and chronic myocardial infarction by cardiovascular magnetic resonanceBulluck H.; Rosmini S.; Abdel-Gadir A.; Bhuva A.N.; Treibel T.A.; Fontana M.; Weinmann S.; Sirker A.; Herrey A.S.; Manisty C.; Moon J.C.; Hausenloy D.J. 
3313-Sep-2021IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST ActionLecour, Sandrine; Andreadou, Ioanna; Bøtker, H.E.; Davidson, Sean M.; Heusch, Gerd; Ruiz-Meana, Marisol; Schulz, Rainer; Zuurbier, Coert J.; Ferdinandy, Peter; Hausenloy, Derek J. ; Adamovski, P.; Batirel, S.; Barteková, M.; Bertrand, L.; Beauloye, C.; Biedermann, D.; Borutaite, V.; Chlopicki, S.; Dambrova, M.; Davidson, Sean M.; Devaux, Y.; Di Lisa, F.; Djuric, D.; Erlinge, D.; Falcao-Pires, I.; Galatou, E.; Garcia-Sosa, A.; Girao, H.; Giricz, Z.; Gyongyosi, M.; Hausenloy, Derek J. ; Healy, D.; Jakovljevic, V.; Jovanic, J.; Kararigas, G.; Kerkal, R.; Kolar, F.; Kwak, B.; Leszek, P.; Liepinsh, E.; Lonborg, J.; Longnus, S.; Marinovic, J.; Muntean, D.M.; Nezic, L.; Ovize, M.; Pagliaro, P.; Da Costa Gomes, C.P.; Pernow, J.; Persidis, A.; Pischke, S.E.; Podesser, B.; Poto?njak, I.; Prunier, F.; Ravingerova, T.; Serban, A.; Slagsvold, K.; van Royen, N.; Turan, B.; Vendelin, M.; Walsh, S.; Zidar, N.; Zuurbier, Coert J.; Yellon, D.; on behalf ofthe European Union-CARDIOPROTECTION COST ACTION CA16225.
342018Incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysisBulluck, H; Chan, M.H.H; Paradies, V; Yellon, R.L; Ho, H.H; Chan, M.Y ; Chin, C.W.L; Tan, J.W ; Hausenloy, D.J 
3511-Jul-2019Independent Predictors of Cardiac Mortality and Hospitalization for Heart Failure in a Multi-Ethnic Asian ST-segment Elevation Myocardial Infarction Population Treated by Primary Percutaneous Coronary InterventionBulluck, Heerajnarain; Zheng, Huili ; Chan, Mark Y ; Foin, Nicolas; Foo, David C; Lee, Chee W ; Lim, Soo T ; Sahlen, Anders ; Tan, Huay C ; Tan, Jack W ; Tong, Khim L ; Wong, Aaron S; Wong, Philip E; Yeo, Khung K ; Foo, Ling L; Chua, Terrance S; Koh, Tian H ; Hausenloy, Derek J 
162019Interrogation of the infarcted and salvaged myocardium using multi-parametric mapping cardiovascular magnetic resonance in reperfused ST-segment elevation myocardial infarction patientsHausenloy, D.J. ; Lim, M.X. ; Chan, M.H.H. ; Paradies, V.; Francis, R.; Kotecha, T.; Knight, D.S.; Fontana, M.; Kellman, P.; Moon, J.C.; Bulluck, H.
172017Is there a role for ischaemic conditioning in cardiac surgery?Hausenloy, D ; Candilio, L
182016Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discoveryHausenloy, D.J ; Barrabes, J.A; Bøtker, H.E; Davidson, S.M; Di Lisa, F; Downey, J; Engstrom, T; Ferdinandy, P; Carbrera-Fuentes, H.A ; Heusch, G; Ibanez, B; Iliodromitis, E.K; Inserte, J; Jennings, R; Kalia, N; Kharbanda, R; Lecour, S; Marber, M; Miura, T; Ovize, M; Perez-Pinzon, M.A; Piper, H.M; Przyklenk, K; Schmidt, M.R; Redington, A; Ruiz-Meana, M; Vilahur, G; Vinten-Johansen, J; Yellon, D.M; Garcia-Dorado, D
191-Dec-2021Lipid profiles and outcomes of patients with prior cancer and subsequent myocardial infarction or strokeKoo, CY ; Zheng, H ; Tan, LL ; Foo, LL; Seet, R ; Chong, JH ; Hausenloy, DJ ; Chng, WJ ; Richards, AM ; Lee, CH ; Chan, MY 
202013Loss of PINK1 Increases the Heart's Vulnerability to Ischemia-Reperfusion InjurySiddall H.K.; Yellon D.M.; Ong S.-B.; Mukherjee U.A.; Burke N.; Hall A.R.; Angelova P.R.; Ludtmann M.H.R.; Deas E.; Davidson S.M.; Mocanu M.M.; Hausenloy D.J.